Previously, DJ-1 modulator UCP0054278/comp-B was identified by virtual screening, where comp-B interacts with DJ-1 to produce antioxidant and neuroprotective responses in Parkinson’s disease models. However, the effect of comp-B in an in vivo Alzheimer’s disease (AD) model is yet undetermined. Thus, we examined the effect of comp-B on spatial learning, memory, and amyloid-β (Aβ) clearance in a transgenic mouse model of AD. We found that comp-B resolved the cognitive deficits, reduced insoluble Aβ42 levels, and prevented the degeneration of synaptic functions, thereby suggesting that comp-B may become a major compound for AD treatment.
NagakuboD, TairaT, KitauraH, IkedaM, TamaiK, Iguchi-ArigaSMM, ArigaH (1997) DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commum31, 509–513.
2.
BonifatiV, RizzuP, van BarenMJ, SchaapO, BreedveldGJ, KriegerE, DekkerMC, SquitieriF, IbanezP, JoosseM, van DongenJW, VanacoreN, van SwietenJC, BriceA, MecoG, van DuijnCM, OostraBA, HeutinkP (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science299, 256–259.
3.
TairaT, SaitoY, NikiT, Iguchi-ArigaSM, TakahashiK, ArigaH (2005) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep5, 213–218.
4.
IshikawaS, TairaT, NikiT, Takahashi-NikiK, ArigaH, Iguchi-ArigaSM (2010) Human DJ-1-specific transcriptional activation of tyrosine hydroxylase gene. J Biol Chem285, 39718–39731.
5.
MiyazakiS, YanagidaT, NunomeK, IshikawaS, IndenM, KitamuraY, NakagawaS, TairaT, HirotaK, NiwaM, Iguchi-ArigaSM, ArigaH(2008) DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson’s disease model rats. J Neurochem105, 2418–2434.
6.
YamaneK, KitamuraY, YanagidaT, TakataK, YanagisawaD, TaniguchiT, TairaT, ArigaH (2009) Oxidative neurodegeneration is prevented by UCP0045037, an allosteric modulator for the reduced form of DJ-1, a wild-type of familial Parkinson’s disease-linked PARK7. Int J Mol Sci10, 4789–4804.
7.
YanagidaT, KitamuraY, YamaneK, TakahashiK, TakataK, YanagisawaD, YasuiH, TaniguchiT, TairaT, HondaT, ArigaH (2009) Protection against oxidative stress-induced neurodegeneration by a modulator for DJ-1, the wild-type of familial Parkinson’s disease-linked PARK7. J Pharmacol Sci109, 463–468.
8.
IndenM, KitamuraY, TakahashiK, TakataK, ItoN, NiwaR, FunayamaR, NishimuraK, TaniguchiT, HondaT, TairaT, ArigaH (2011) Protection against dopaminergic neurodegeneration in Parkinson’s disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson’s disease-linked PARK7. J Pharmacol Sci117, 189–203.
9.
HardyJ, SelkoeDJ (2002) The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science297, 353–356.
MatsumuraA, EmotoMC, SuzukiS, IwaharaN, HisaharaS, KawamataJ, SuzukiH, YamauchiA, Sato-AkabaH, FujiiHG, ShimohamaS (2015) Evaluation of oxidative stress in the brain of a transgenic mouse model of Alzheimer disease by in vivo electron paramagnetic resonance imaging. Free Radic Biol Med85, 165–173.
13.
ProxJ, BernreutherC, AltmeppenH, GrendelJ, GlatzelM, D’HoogeR, StroobantsS, AhmedT, BalschunD, WillemM, LammichS, IsbrandtD, SchweizerM, HorréK, De StrooperB, SaftigP (2013) Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. J Neurosci33, 12915–12928.
